OMIA:000029-9615 : Alloxan-diabetes in Canis lupus familiaris
Categories: Homeostasis / metabolism phene
Links to MONDO diseases: No links.
Mendelian trait/disorder: no
Considered a defect: yes
Key variant known: no
Cross-species summary: Alloxan is an organic compound that causes diabetes mellitus by partial degradation of the beta (β) cells of pancreatic islets, which reduces the quality and quantity of insulin.
Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.
|1996||Matsunaga, T., Okumura, K., Ishizaka, H., Tsunoda, R., Tayama, S., Tabuchi, T., Yasue, H. :|
|Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes Journal of Cardiovascular Pharmacology 28:60-67, 1996. Pubmed reference: 8797137 .|
|1995||Damge, C., Hillairebuys, D., Puech, R., Hoeltzel, A., Michel, C., Ribes, G. :|
|Effects of orally administered insulin nanocapsules in normal and diabetic dogs Diabetes Nutrition & Metabolism 8:3-9, 1995.|
|1993||Rastogi, K.S., Brubaker, P.L., Kawasaki, A., Efendic, S., Vranic, M. :|
|Increase in somatostatin to glucagon ratio in islets of alloxan-diabetic dogs - Effect of insulin-induced euglycemia Canadian Journal of Physiology and Pharmacology 71:512-517, 1993. Pubmed reference: 7902197 .|
- Created by Frank Nicholas on 06 Sep 2005
- Changed by Imke Tammen2 on 20 Mar 2022